发明申请
US20050070475A1 Long lasting fusion peptide inhibitors of viral infection 失效
长期的病毒感染融合肽抑制剂

Long lasting fusion peptide inhibitors of viral infection
摘要:
Peptides exhibiting anti-viral and anti-fusogenic activity are modified to provide greater stability and improved half-life in vivo. The selected peptides include fusion inhibitors DP178 and DP107 and related peptides and analogs thereof. The modified peptides are capable of forming covalent bonds with one or more blood components, preferably a mobile blood component.
信息查询
0/0